Current Clinical Trials for Prostate

GCC 0605 - A Phase II Study Evaluating Bone Marrow-Sparing, Image-Guided Pelvic Intensity-Modulated Radiotherapy (IMRT) with Cesium-131 Brachytherapy Boost, Adjuvant Chemotherapy, and Long-Term Hormonal Ablation in Patients with High Risk, Non-Metastatic Prostate Cancer.

GCC 1006 - Strength Training Exercise in Prostate Cancer Patients

GCC 1045 - E3805: Chemohormonal Therapy vs Androgen Ablation in Extensive Prostate Cancer

GCC 1101 - A Randomized Discontinuation Phase 2 Study of AZD0530 as a Metastasis Inhibitor in Castrate Resistant Prostate Cancer

GCC 1112 - Randomized Phase II trial of short-course androgen deprivation therapy +/- Avastin for PSA recurrence of prostate cancer after definitive local therapy

GCC 1147 - A REGISTRY OF SIPULEUCEL-T THERAPY IN MEN WITH ADVANCED PROSTATE CANCER

RTOG 0232 - A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy with Brachytherapy Alone for Selected Patients with Intermediate Risk Prostatic Carcinoma

RTOG 0534 - A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPORT) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy

Email this Page                                                                     Print this Page